fbpx

Breast Cancer Trials

ANZGOG subgroup study of ovarian and breast cancer patients EMBRACE closes to recruitment

EMBRACE is a Phase II clinical trial of the PARP inhibitor, olaparib, in HR-deficient metastatic breast and relapsed ovarian cancer in patients without germline mutations in BRCA1 and BRCA2. Dr Katrin Sjoquist, Medical Oncologist [...]

ANZGOG subgroup study of ovarian and breast cancer patients EMBRACE closes to recruitment2022-07-01T11:34:46+10:00

Breast Cancer Trials (BCT) 43rd Annual Scientific Meeting

The Breast Cancer Trials (BCT) Annual Scientific Meeting (ASM) is the premier event for breast cancer clinical trials research in Australia and New Zealand. The theme for the 2022 ASM is ‘breast cancer in young women’, with a number [...]

Breast Cancer Trials (BCT) 43rd Annual Scientific Meeting2022-03-24T23:18:24+11:00
Go to Top